Padmanabhan R
Department of Anatomy, Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
Reprod Toxicol. 1998 Mar-Apr;12(2):139-51. doi: 10.1016/s0890-6238(97)00153-6.
Caudal regression syndrome (CRS) comprises developmental anomalies of the caudal vertebrae, neural tube, urogenital and digestive organs, and hind limbs, the precursors of all of which are derived from the caudal eminence. Although the syndrome is well recognized, the etiology and pathogenetic mechanisms are poorly understood. Genetic and experimental models may provide some important clues to the early events that precede the dysmorphogenesis in CRS. The objectives of this study were to determine the susceptible stages for induction of CRS and to ascertain the early events that precede the development of this syndrome in a mouse model. Single oral doses of 100, 150, or 200 mg/kg retinoic acid (RA) were administered to TO mice on one of Gestation Days (GD) 8 to 12, and fetuses were observed on GD 18. All doses administered on GD 8 or 9 resulted in CRS in a large number of survivors. Agenesis of the tail, caudal vertebral defects, spina bifida occulta/aperta, imperforate anus, rectovesicle or rectourethral fistula, renal malformations, cryptorchidism, gastroschisis, and limb malformations, including the classical mermaid syndrome (sirenomelia), were characteristic features of this animal model. Several craniofacial malformations accompanied CRS in the GD 8 treatment group. Chronologic examination of treated embryos at early stages revealed pronounced cell death in the caudal median axis, hindgut, and neural tube and consequently, failure of development of the tail bud in the high-dose groups. In the 100 mg/kg RA group, patches of hemorrhage occurred initially that subsequently coalesced into large hematomas and the tail progressively regressed. Histologic examination revealed the onset and progression of hemorrhage, edema, and cell death in these embryos. Transillumination and histologic preparations also revealed dilation of the caudal neural tube in the prospective CRS embryos. Thus, a combination of cell death, vascular disruption, and tissue deficiency appears to be the highlight of caudal regression in this model. Symmelia appeared to be due to failure of fission or due to the merger of limb fields rather than a result of fusion of two limb buds. The data are also indicative of caudal agenesis in the high-dose RA groups and caudal regression due to a combination of vascular disruption, edema, and cell death in the lower dose groups of TO mouse embryos.
尾椎退化综合征(CRS)包括尾椎、神经管、泌尿生殖器官和消化器官以及后肢的发育异常,所有这些结构的原基均来源于尾侧隆起。尽管该综合征已广为人知,但其病因和发病机制仍不清楚。遗传和实验模型可能为CRS畸形发生之前的早期事件提供一些重要线索。本研究的目的是确定诱导CRS的易感阶段,并在小鼠模型中确定该综合征发生之前的早期事件。在妊娠第8至12天的某一天,给TO小鼠单次口服100、150或200mg/kg维甲酸(RA),并在妊娠第18天观察胎儿。在妊娠第8天或第9天给予的所有剂量均导致大量存活胎儿出现CRS。尾缺如、尾椎骨缺损、隐性/显性脊柱裂、肛门闭锁、直肠膀胱或直肠尿道瘘、肾畸形、隐睾、腹裂以及肢体畸形,包括典型的美人鱼综合征(并腿畸形),是该动物模型的特征性表现。在妊娠第8天治疗组中,CRS伴有几种颅面畸形。对早期处理胚胎的时序检查显示,高剂量组尾中轴、后肠和神经管中有明显的细胞死亡,因此尾芽发育失败。在100mg/kg RA组中,最初出现出血斑,随后合并成大血肿,尾巴逐渐退化。组织学检查显示这些胚胎中出血、水肿和细胞死亡的发生和进展。透照和组织学切片还显示,未来发生CRS的胚胎中尾神经管扩张。因此,细胞死亡、血管破坏和组织缺损的组合似乎是该模型中尾椎退化的突出表现。并腿畸形似乎是由于分裂失败或肢体区域融合,而不是两个肢芽融合的结果。这些数据还表明,高剂量RA组存在尾缺如,而低剂量组TO小鼠胚胎中,由于血管破坏、水肿和细胞死亡的组合导致尾椎退化。